40.16
-3.71
(-8.46%)
At close: January 10 at 4:00:01 PM EST
40.93
+0.77
+(1.92%)
After hours: January 10 at 5:01:03 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
Operating Cash Flow
-36,818.00
-27,637.00
-12,454.00
Investing Cash Flow
-514.00
-2,088.00
-2,122.00
Financing Cash Flow
-502.00
37,628.00
41,420.00
End Cash Position
6,916.00
36,553.00
28,650.00
Interest Paid Supplemental Data
152.00
144.00
--
Capital Expenditure
-514.00
-2,088.00
-2,122.00
Issuance of Capital Stock
--
38,017.00
37,807.00
Issuance of Debt
--
--
4,000.00
Repayment of Debt
-503.00
-393.00
-389.00
Free Cash Flow
-37,332.00
-29,725.00
-14,576.00
12/31/2021 - 6/21/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SYRE Spyre Therapeutics, Inc.
22.46
-6.49%
MLYS Mineralys Therapeutics, Inc.
9.87
-11.87%
PLRX Pliant Therapeutics, Inc.
12.01
-4.76%
KALV KalVista Pharmaceuticals, Inc.
7.85
-4.73%
PRQR ProQR Therapeutics N.V.
2.4200
-7.63%
QTTB Q32 Bio Inc.
3.3400
+2.14%
BSLN.SW Basilea Pharmaceutica AG
42.10
-1.75%
DSGN Design Therapeutics, Inc.
4.5200
-10.94%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
PTGX Protagonist Therapeutics, Inc.
36.61
-2.68%